Facilities

The HDS business unit combines novel isogenic and non-isogenic cell-based assays with 15 years of oncology, cell biology and contract research expertise to deliver a first-class service out of dedicated facility on Cambridge Science Park, UK.

The HDS site on Cambridge Science Park operates all assay development and screening projects for the Horizon Discovery group. This includes client projects, internal research and development, collaborations with academic and industry partners and formatting of assays for HTS or in vivo studies performed by Horizon’s exclusive discovery services partner TD2 at their state-of-art facility in Scottsdale, Arizona, USA.

Photo Gallery

Assays routinely offered at our Assay Development and Screening Facility include:

X-MAN Pathways Assays
Bespoke Isogenic Services
Compound Screening in Cellular Assays
Tumor Microenvironment/Specialist Studies
Invasion and Migration Assays

Assays routinely offered at TD2 HTS and In-Vivo Facility include:

High-throughput X-MAN Pathways Assays
Bespoke Isogenic Animal Model Development
In-Vivo X-MAN Pathways Assays
Target & Biomarker Validation
Clinical Trial Design & Patient Selection